30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Voice of Industry

Medartis: Profile of a Newly-Public Orthopaedic Company

Medartis went public on the SIX Swiss Exchange in March, securing proceeds to fund product development, international expansion and potential acquisitions. Their public launch provided deeper insight into the company’s position within the global orthopaedic trauma space. We reviewed Medartis’ 2017 and 2018 strategic announcements, and spoke with leadership to get a better sense of the company’s recent and future movement.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.